Wells Fargo & Company MN Reduces Stake in The Cooper Companies, Inc. (NASDAQ:COO)

Wells Fargo & Company MN lowered its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 0.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,310,347 shares of the medical device company's stock after selling 10,280 shares during the period. Wells Fargo & Company MN owned 0.66% of Cooper Companies worth $120,460,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Fulton Bank N.A. grew its position in shares of Cooper Companies by 3.0% in the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company's stock valued at $342,000 after purchasing an additional 109 shares during the period. Torray Investment Partners LLC lifted its position in shares of Cooper Companies by 0.8% in the fourth quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company's stock valued at $1,488,000 after acquiring an additional 132 shares in the last quarter. Mather Group LLC. raised its stake in Cooper Companies by 7.4% in the 4th quarter. Mather Group LLC. now owns 1,926 shares of the medical device company's stock valued at $177,000 after purchasing an additional 133 shares during the last quarter. MassMutual Private Wealth & Trust FSB grew its holdings in shares of Cooper Companies by 15.6% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company's stock worth $93,000 after buying an additional 136 shares in the last quarter. Finally, Greenleaf Trust raised its position in shares of Cooper Companies by 5.0% in the fourth quarter. Greenleaf Trust now owns 2,915 shares of the medical device company's stock valued at $268,000 after buying an additional 139 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company's stock.

Remove Ads

Cooper Companies Stock Performance

Shares of COO stock traded up $0.28 during trading hours on Friday, hitting $75.65. The stock had a trading volume of 618,243 shares, compared to its average volume of 1,384,012. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The firm has a market capitalization of $15.13 billion, a PE ratio of 38.77, a PEG ratio of 2.25 and a beta of 1.01. The stock's 50 day moving average is $84.99 and its 200 day moving average is $94.84. The Cooper Companies, Inc. has a twelve month low of $69.81 and a twelve month high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting analysts' consensus estimates of $0.92. The firm had revenue of $964.70 million during the quarter, compared to analysts' expectations of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. As a group, research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have recently issued reports on COO. Stifel Nicolaus dropped their price target on Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a research report on Friday, March 7th. Robert W. Baird dropped their price objective on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a report on Friday, March 7th. Citigroup reduced their target price on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research note on Friday, March 7th. Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a report on Friday, March 7th. Finally, BNP Paribas upgraded shares of Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Four investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $110.25.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.